117 results
Page 3 of 6
8-K
EX-99.1
ead53u4b ui6ag9xq5wi
26 Jul 23
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
EX-99.1
9fc25hq ru0lgi6tuty6
26 Apr 23
Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
PRE 14A
nxbpa4w00ygac371
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-1.1
qk1vo ffm
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
424B5
36doujw6465xo0g
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
ojson u24ce03
29 Mar 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
dcux1vuqm2s
26 Oct 22
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-99.1
eufodlcbc8oi7szmvhni
27 Jul 22
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
8ownu
27 Apr 22
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
enspqedpmb 39
9 Feb 22
Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
l55d2zxcgl4eiy7w53pi
3 Nov 21
Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:10pm